These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The advent of ivermectin: people, partnerships, and principles. Crump A Trends Parasitol; 2014 Sep; 30(9):423-5. PubMed ID: 25168585 [TBL] [Abstract][Full Text] [Related]
3. Ivermectin, 'wonder drug' from Japan: the human use perspective. Crump A; Ōmura S Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(2):13-28. PubMed ID: 21321478 [TBL] [Abstract][Full Text] [Related]
4. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. Gustavsen KM; Bradley MH; Wright AL Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393 [TBL] [Abstract][Full Text] [Related]
5. Ethical issues in funding research and development of drugs for neglected tropical diseases. Oprea L; Braunack-Mayer A; Gericke CA J Med Ethics; 2009 May; 35(5):310-4. PubMed ID: 19407037 [TBL] [Abstract][Full Text] [Related]
6. Ivermectin and onchocerciasis: is it all solved? Hopkins AD Eye (Lond); 2005 Oct; 19(10):1057-66. PubMed ID: 16304585 [TBL] [Abstract][Full Text] [Related]
7. Nobel prize for the artemisinin and ivermectin discoveries: a great boost towards elimination of the global infectious diseases of poverty. Tambo E; Khater EI; Chen JH; Bergquist R; Zhou XN Infect Dis Poverty; 2015 Dec; 4():58. PubMed ID: 26708575 [TBL] [Abstract][Full Text] [Related]
8. Mass treatment with ivermectin: an underutilized public health strategy. Speare R; Durrheim D Bull World Health Organ; 2004 Aug; 82(8):562. PubMed ID: 15375444 [No Abstract] [Full Text] [Related]
9. Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations. Crump A J Antibiot (Tokyo); 2017 May; 70(5):495-505. PubMed ID: 28196978 [TBL] [Abstract][Full Text] [Related]
10. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007). Hooper PJ; Bradley MH; Biswas G; Ottesen EA Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394 [TBL] [Abstract][Full Text] [Related]
11. Drug discovery and development for neglected parasitic diseases. Renslo AR; McKerrow JH Nat Chem Biol; 2006 Dec; 2(12):701-10. PubMed ID: 17108988 [TBL] [Abstract][Full Text] [Related]
12. Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations. Bush S; Hopkins AD Acta Trop; 2011 Sep; 120 Suppl 1():S169-72. PubMed ID: 21470555 [TBL] [Abstract][Full Text] [Related]
13. Ivermectin - Old Drug, New Tricks? Laing R; Gillan V; Devaney E Trends Parasitol; 2017 Jun; 33(6):463-472. PubMed ID: 28285851 [TBL] [Abstract][Full Text] [Related]
14. Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug". Sulik M; Antoszczak M; Huczyński A; Steverding D Eur J Med Chem; 2023 Dec; 261():115838. PubMed ID: 37793327 [TBL] [Abstract][Full Text] [Related]